Inventor · disambiguated record
Michael Reardon
Also filed as: REARDON MICHAEL · REARDON MICHAEL R
16 granted patents·3 pending applications·65 citations·filing 2009–2023
92Inventor score
Top patents by PatentIndex Score
19 records- 0195US10954230B2Method of preparing glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2020·Granted Mar 23, 2021·4 cites·3 claims
- 0292US11279725B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2019·Granted Mar 22, 2022·6 cites·19 claims
- 0392US10604518B2Method of preparing glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2018·Granted Mar 31, 2020·5 cites·7 claims
- 0490US11274121B2Methods for antibody drug conjugation, purification, and formulationIMMUNOGEN INC·Filed 2019·Granted Mar 15, 2022·6 cites·39 claims
- 0590US10065949B2Method of preparing glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2017·Granted Sep 4, 2018·8 cites·7 claims
- 0689US9682975B2Method of preparing glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Granted Jun 20, 2017·10 cites·7 claims
- 0787US10464962B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2016·Granted Nov 5, 2019·5 cites·6 claims
- 0886US11396519B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2020·Granted Jul 26, 2022·1 cites·20 claims
- 0986US10851117B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2019·Granted Dec 1, 2020·2 cites·20 claims
- 1086US8835614B2Oligosaccharide-protein conjugatesAVILA LUIS Z·Filed 2009·Granted Sep 16, 2014·10 cites·15 claims
- 1184US9493498B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2014·Granted Nov 15, 2016·6 cites·14 claims
- 1281US10913713B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2019·Granted Feb 9, 2021·1 cites·20 claims
- 1379US12252504B2Oligosaccharide-protein conjugatesGENZYME CORP·Filed 2022·Granted Mar 18, 2025·0 cites·5 claims
- 1477US11981688B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2022·Granted May 14, 2024·0 cites·20 claims
- 1575US2023286914A1Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2023·Application pending·0 cites
- 1671US11591296B2Methods of preparing cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2021·Granted Feb 28, 2023·0 cites·18 claims
- 1770US8877722B2Compositions for inhibiting gene expression and uses thereofAGRAWAL SUDHIR·Filed 2011·Granted Nov 4, 2014·1 cites·10 claims
- 1863US2022267371A1Methods for antibody drug conjugation, purification, and formulationIMMUNOGEN INC·Filed 2022·Application pending·0 cites
- 1954US2015044196A1Compositions for Inhibiting Gene Expression and Uses ThereofIDERA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Reardon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →